Trial Profile
HIV-DNA vaccine in treatment-naive patients with HIV-1 infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2022
Price :
$35
*
At a glance
- Drugs HIV DNA vaccine (Primary) ; HIV DNA vaccine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors FIT Biotech
- 28 Apr 2012 Results published in Vaccine.
- 19 Jul 2010 Positive results from this trial have been presented at the XVIII International AIDS 2010 Conference, according to a FIT Biotech media release. Results were discussed further within the media release.